March 19, 2021


This issue of OR Manager is being published just about a year after the nationwide shutdown that was implemented to curb the spread of SARS-CoV-2, the virus that causes COVID-19. Failures on many fronts ensued in the months that followed, with an excessive death toll and unprecedented disruptions in every aspect of life throughout 2020. At the same time, amazing progress was made in the development of new vaccines, two of which the US Food and Drug Administration approved under Emergency Use Authorization (EUA) by year end. EUA of a third vaccine followed in February 2021.

Welcome to OR Manager, your source of information and insight into the clinical and business management of the surgical suite. This article is only available to OR Manager subscribers. To read this article, and gain access to all OR Manager resources, please log in below:

  Join the OR Manager Community! OR Manager is the trusted source for perioperative leaders, providing critical information, analysis, and best practices for management of the surgical suite. Join as a Premium Subscriber to access all articles online including archives, the digital issue of OR Manager each month, eligibility for CE contact hours, registration discounts on conferences and more. We also offer a complimentary Plus subscription to those who qualify and a complimentary Community subscription.

Explore Subscription Options

Please contact our Customer Service Team if you are unable to log in at [email protected] or 1-888-707-5814.

Live chat by BoldChat